Monthly Archives: November 2014

Featured Stories
Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Medtronic Plans Layoffs, as Infuse Bone Graft Controversy Continues to Weigh on Spinal Business

Medtronic’s spinal division continues to take a huge hit thanks to the controversy surrounding its Infuse Bone Graft product. According to a report from MassDevice.com, the company’s latest earnings report stated that the division saw Infuse sales decline 26% in the first quarter of 2012, and now Medtronic is talking ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Dozens Receive Nonsterile Simulated Saline Solution

Dozens-Receive-Nonsterile-Simulated-Saline-Solution

The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

FDA Warning About Surgical Tool That May Spread Cancer

On Monday, the Food and Drug Administration (FDA) updated an earlier safety alert to advise that the power morcellator should no longer be used in uterine surgeries for “the vast majority” of women because of the risk of spreading cancer. … Continue reading

Posted in Defective Medical Devices, Health Concerns |

Radiation from Cell Phones Linked to Brain Cancer, Study Suggests

Cell phone use is linked to a risk of brain cancer, a study published in the International Journal of Oncology suggests. Researchers analyzed the relationship between mobile phone use and glioma, a specific type of brain cancer that has a … Continue reading

Posted in Legal News |

Hookah Smoking May Increase Leukemia Risk

Researchers from San diegohave found that smoking hookah – a type of flavored tobacco – could lead to an increase in leukemia. Hookah smoke doubles exposure to benzene, which the U.S. National Toxicology Program classifies as a Group 1 carcinogen, … Continue reading

Posted in Health Concerns, Toxic Substances |

Health Canada Warns of Insulin Pump Tubing Detachment

Insulin pump infusion sets manufactured by Medtronic of Canada Inc., Roche Diagnostics, LifeScan Canada Inc, and Auto Control Medical Inc. have a risk of tubing detachment, according to a safety notification issued by Unomedical a/s in consultation with Health Canada. … Continue reading

Posted in Legal News |

Sun Pharmaceutical’s Effexor Recalled for the Second Time This Year

Sun Pharmaceutical Industries Ltd. has recalled 68,000 bottles of the antidepressant Effexor (venlafaxine), in the second recall of the drug this year, the Food and Drug Administration (FDA) said. In both instances, the recalled drug was manufactured at the Indian … Continue reading

Posted in Defective Products, Pharmaceuticals, Product Recalls, Recalled Drugs |

Stelara Linked to Risk of Serious Skin Conditions

Stelara, a drug used to treat moderate to severe plaque psoriasis and active psoriatic arthritis, has been linked to a risk of severe skin conditions. According to a safety announcement issued on November 21st on Health Canada’s website, Stelara has … Continue reading

Posted in Legal News |

Patients with Knee Problems May Want to Reconsider before Undergoing Knee Replacement

Getting a total knee replacement may seem like an appealing option for someone suffering from sore and creaky knees, but these devices may not be as beneficial as one would hope, according to Well, the New York Times health blog. … Continue reading

Posted in Legal News |

Energy Drinks Can be Deadly for Children

New research shows that children face serious and possibly deadly side effects from the consumption of energy drinks. Between 2010 and 2013, poison control centers received more than 5,000 reports of people who got sick from energy drinks, NBC News … Continue reading

Posted in Food Products, Health Concerns |

Regulators Review Death Risk Associated with Long-Term Use of Duel Antiplatelet Therapy

Preliminary data from a clinical trial has prompted safety regulators to review the safety of using duel antiplatelet therapy long-term. On Sunday, the U.S. Food and Drug Administration (FDA) issued a safety announcement stating that it was evaluating this data. … Continue reading

Posted in Legal News |

Johnson & Johnson to Pay More than $2.2 Billion in Civil and Criminal Settlements

Health care giant Johnson & Johnson and its subsidiaries will pay more than $2.2 billion to resolve criminal and civil cases arising from allegations relating to the drugs Risperdal (risperidone), Invega (paliperidone) and Natrecor (nesiritide). The allegations include promotion for … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.